Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.06.2020 | Case report

Azithromycin/hydroxychloroquine

Prolongation of the QT interval: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Molina JM, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Medecine et Maladies Infectieuses 50: 384, No. 4, Jun 2020. Available from: URL: http://doi.org/10.1016/j.medmal.2020.03.006 Molina JM, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Medecine et Maladies Infectieuses 50: 384, No. 4, Jun 2020. Available from: URL: http://​doi.​org/​10.​1016/​j.​medmal.​2020.​03.​006
Metadaten
Titel
Azithromycin/hydroxychloroquine
Prolongation of the QT interval: case report
Publikationsdatum
01.06.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-79847-4

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Moxifloxacin